301 related articles for article (PubMed ID: 15494894)
1. Recent developments in the management of herpes simplex virus infection in HIV-infected persons.
Bartlett JG
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S237-9. PubMed ID: 15494894
[No Abstract] [Full Text] [Related]
2. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA;
J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
Warren T; Harris J; Brennan CA
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
[TBL] [Abstract][Full Text] [Related]
4. Trial shows HSV-2 suppression can reduce HIV shedding.
IAVI Rep; 2006; 10(1):20. PubMed ID: 16628770
[No Abstract] [Full Text] [Related]
5. [Herpes genitalis, an underrated disease?].
Hautarzt; 1997 Jan; 48(1 Suppl Herpes):1-8. PubMed ID: 9402418
[No Abstract] [Full Text] [Related]
6. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
7. HSV shedding.
Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
Antiviral Res; 2004 Aug; 63 Suppl 1():S19-26. PubMed ID: 15450382
[TBL] [Abstract][Full Text] [Related]
8. Surgical excision for vegetative herpes simplex virus infection.
Chung VQ; Parker DC; Parker SR
Dermatol Surg; 2007 Nov; 33(11):1374-9. PubMed ID: 17958595
[No Abstract] [Full Text] [Related]
9. HSV-2 transmission.
Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
Antiviral Res; 2004 Aug; 63 Suppl 1():S27-35. PubMed ID: 15450383
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
11. HSV-2 suppression reduces HIV and HSV shedding.
Collins S
GMHC Treat Issues; 2005 Dec; 19(12):11. PubMed ID: 16909510
[No Abstract] [Full Text] [Related]
12. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
13. HIV/AIDS. Prevention cocktails: combining tools to Stop HIV's spread.
Cohen J
Science; 2005 Aug; 309(5737):1002-5. PubMed ID: 16099959
[No Abstract] [Full Text] [Related]
14. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus type 2: epidemiology and management options in developing countries.
Paz-Bailey G; Ramaswamy M; Hawkes SJ; Geretti AM
Postgrad Med J; 2008 Jun; 84(992):299-306. PubMed ID: 18644920
[TBL] [Abstract][Full Text] [Related]
17. Treatment of genital herpes infections in HIV-infected patients.
Foley E; Patel R
J HIV Ther; 2004 Feb; 9(1):14-8. PubMed ID: 15071425
[TBL] [Abstract][Full Text] [Related]
18. ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists, number 57, November 2004. Gynecologic herpes simplex virus infections.
ACOG Committee on Practice Bulletins--Gynecology
Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1111-8. PubMed ID: 15516420
[TBL] [Abstract][Full Text] [Related]
19. Observations on recovery from and recurrence of HSV-2 infections in adult mice that were rescued from lethal vaginal infection by antiviral therapy.
Parr EL; Holliday EM; Collard MW; Parr MB
Arch Virol; 2005 Sep; 150(9):1885-902. PubMed ID: 15824886
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus type 2 acute retinal necrosis 9 years after neonatal herpes.
Landry ML; Mullangi P; Nee P; Klein BR
J Pediatr; 2005 Jun; 146(6):836-8. PubMed ID: 15973328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
